WallStreetZenWallStreetZen

NASDAQ: PETQ
Petiq Inc Stock Forecast, Predictions & Price Target

Analyst price target for PETQ

Based on 1 analyst offering 12 month price targets for Petiq Inc.
Min Forecast
$28.00+68.67%
Avg Forecast
$28.00+68.67%
Max Forecast
$28.00+68.67%

Should I buy or sell PETQ stock?

Based on 1 analyst offering ratings for Petiq Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PETQ stock forecasts and price targets.

PETQ stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-19

1 of 1

Forecast return on equity

Is PETQ forecast to generate an efficient return?

Forecast return on assets

Is PETQ forecast to generate an efficient return on assets?

PETQ revenue forecast

What is PETQ's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$1.1B+4.24%
Avg 2 year Forecast
$1.2B+10.35%
Avg 3 year Forecast
$1.3B+18.06%
PETQ's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PETQ revenue growth forecast

How is PETQ forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
5.48%
Industry
9.16%
Market
10.16%
PETQ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PETQ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PETQ vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
PETQ$16.60$28.00+68.67%Strong Buy
PAHC$13.61$16.00+17.56%Hold
ORGO$2.98$4.83+62.18%Strong Buy
ESPR$2.09$12.00+474.16%Buy
HROW$10.32$26.00+151.94%Strong Buy

Petiq Stock Forecast FAQ

Is Petiq Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PETQ) stock is to Strong Buy PETQ stock.

Out of 1 analyst, 1 (100%) are recommending PETQ as a Strong Buy, 0 (0%) are recommending PETQ as a Buy, 0 (0%) are recommending PETQ as a Hold, 0 (0%) are recommending PETQ as a Sell, and 0 (0%) are recommending PETQ as a Strong Sell.

If you're new to stock investing, here's how to buy Petiq stock.

What is PETQ's revenue growth forecast for 2024-2026?

(NASDAQ: PETQ) Petiq's forecast annual revenue growth rate of 5.48% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Petiq's revenue in 2024 is $1,101,963,000.On average, 4 Wall Street analysts forecast PETQ's revenue for 2024 to be $33,806,195,127, with the lowest PETQ revenue forecast at $33,257,389,340, and the highest PETQ revenue forecast at $34,375,779,424. On average, 4 Wall Street analysts forecast PETQ's revenue for 2025 to be $35,789,512,784, with the lowest PETQ revenue forecast at $35,023,268,420, and the highest PETQ revenue forecast at $36,288,815,094.

In 2026, PETQ is forecast to generate $38,290,144,718 in revenue, with the lowest revenue forecast at $38,290,144,718 and the highest revenue forecast at $38,290,144,718.

What is PETQ's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PETQ) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of N/A.

What is PETQ's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PETQ price target, the average PETQ price target is $28.00, with the highest PETQ stock price forecast at $28.00 and the lowest PETQ stock price forecast at $28.00.

The Wall Street analyst predicted that Petiq's share price could reach $28.00 by Mar 19, 2025. The average Petiq stock price prediction forecasts a potential upside of 68.67% from the current PETQ share price of $16.60.

What is PETQ's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PETQ) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.